Bhuvana A Setty
Overview
Explore the profile of Bhuvana A Setty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fetzko S, Gupta A, Setty B, Malone M, Schraw J, Lupo P, et al.
Pediatr Blood Cancer
. 2024 Dec;
72(3):e31477.
PMID: 39654081
Background: Patients with relapsed rhabdomyosarcoma (RMS) are treated with varying approaches and have a poor overall survival (OS). We performed an observational comparison of salvage regimens exploring whether high-dose alkylator...
2.
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb D, Mascarenhas L, et al.
Clin Cancer Res
. 2024 Oct;
30(23):5314-5322.
PMID: 39360936
Purpose: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent osteosarcoma. Nab-paclitaxel has preclinical activity against osteosarcoma and is potentially less myelosuppressive than docetaxel. We...
3.
Upadhyay R, Klamer B, Matsui J, Chakravarthy V, Scharschmidt T, Yeager N, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893209
Background: Pediatric patients with metastatic and/or recurrent solid tumors have poor survival outcomes despite standard-of-care systemic therapy. Stereotactic ablative radiation therapy (SABR) may improve tumor control. We report the outcomes...
4.
Cripe T, Roberts R, Chandler D, Setty B, Chen S, Shenoy A, et al.
Mol Ther Oncol
. 2024 Apr;
32(1):200779.
PMID: 38596308
No abstract available.
5.
Borst A, Eng W, Griffin M, Ricci K, Engel E, Adams D, et al.
Pediatr Blood Cancer
. 2023 Dec;
71(3):e30779.
PMID: 38073018
Background And Objectives: Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA) are rare vascular tumors in children historically associated with significant morbidity and mortality. This study was conducted to determine first-line...
6.
Setty B, Gikandi A, Dubois S
Paediatr Drugs
. 2023 Apr;
25(4):389-397.
PMID: 37014523
Ewing sarcoma is a translocation-associated sarcoma mainly impacting adolescents and young adults. The classic translocation (EWSR1::FLI1) leads to a fusion oncoprotein that functions as an aberrant transcription factor. As such,...
7.
Hou Y, Evenson M, Corliss M, Mahapatra L, Aldawood A, Carpentieri D, et al.
Genet Med
. 2022 Dec;
25(3):100348.
PMID: 36571464
Purpose: RAS genes (HRAS, KRAS, and NRAS) are commonly found to be mutated in cancers, and activating RAS variants are also found in disorders of somatic mosaicism (DoSM). A survey...
8.
Setty B, Wusik K, Hammill A
Pediatr Blood Cancer
. 2022 Sep;
69 Suppl 3:e29320.
PMID: 36070212
Vascular anomalies are a heterogeneous group of disorders that are currently classified based on their clinical and histological characteristics. Over the past decade, there have been significant advances in molecular...
9.
de Souza Fernandez Pereira M, Carr D, Gatti-Mays M, Olsen M, Setty B, Shahwan K, et al.
Cancer J
. 2022 Jul;
28(4):263-269.
PMID: 35880935
Natural killer (NK) cells possess an innate ability to recognize cancer and are key mediators of cytotoxic efficacy for anticancer antibodies. Recent advances in the ability to generate, qualify, and...
10.
Pearson A, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor E, Copland C, et al.
Eur J Cancer
. 2022 Jul;
173:71-90.
PMID: 35863108
The eighth Paediatric Strategy Forum focused on multi-targeted kinase inhibitors (mTKIs) in osteosarcoma and Ewing sarcoma. The development of curative, innovative products in these tumours is a high priority and...